Crossmark

Does ruxolitinib improve survival of persons with MPN-associated myelofibrosis? Should it?

Published Online: 2014-07-16

Published Print: 2014-11

Authors

Barosi, G

Zhang, M-J

Gale, R Peter
License Information

Text and Data Mining valid from 2014-07-16

Version of Record valid from 2014-07-16
More Information

Article History

First Online: 16 July 2014

Competing interests

: RPG is a part-time employee of Celgene Corp. GB participated in advisory boards from Novartis and Sanofi. M-JZ declares no conflict of interest.

Document is current